Evidence map›Paper›PMID 33762824›Full record

ArticleNeuropsychiatric disease and treatment2021

A National Survey of Self-Prescription of Beta-Blockers and Their Relation to Undiscovered Anxiety Among Medical and Pharmacological Students in Saudi Arabia.

Albaraa Alsini, Ishraq Alkhodaidi, Yasir Alsini, Sarh Alsseeni, Shrooq Alkhodaidi, Ehsan Alsini, Asim Alsini, Hamzah Sindi, Khaled Alswat

Open access · goldAbstract read
In one paragraph

Article in Neuropsychiatric disease and treatment, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Albaraa AlsiniResident, Department of Otolaryngology Head & Neck Surgery, Alhada Armed Forces Hospital, Taif, Saudi Arabia.ORCID 0000-0003-4821-8773
Ishraq AlkhodaidiMedical Student, Faculty of Medicine, Taif University, Taif, Saudi Arabia.
Yasir AlsiniPharmD, Alhada Armed Forces Hospital, Taif, Saudi Arabia.
Sarh AlsseeniPharmD Student, Taif University, Taif, Saudi Arabia.
Shrooq AlkhodaidiResident, Department of Dermatology, King Abdulaziz Hospital, Makkah, Saudi Arabia.
Ehsan AlsiniPharmD, Medical Representative in Eli Lilly and Company, Taif, Saudi Arabia.
Asim AlsiniMedical Intern, Faculty of Medicine, Taif University, Taif, Saudi Arabia.
Hamzah SindiMedical Student, Faculty of Medicine, Umm AlQura University, Makkah, Saudi Arabia.
Khaled AlswatProfessor of Medicine, Department of Medicine, School of Medicine, Taif University, Taif, 21944, Saudi Arabia.
Taif University · SAArmed Forces Hospital · SAKing Abdulaziz Hospital · SAUmm al-Qura University · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe development of beta-blocker (BB) medications is considered one of the most critical milestones of drug research. Several trials showed possible anti-anxiety effects of BBs. Our primary goal is to investigate the prevalence of anxiety disorder and the use of BBs as anxiolytic without medical prescription among medical and pharmacological students in Saudi Arabia.

methodsA cross-sectional study was conducted at multiple universities in Saudi Arabia. Students were given a questionnaire containing 44 questions that included demographic data, school location, BB usage behavior, GPA status before and after using BBs, and a GAD-7 anxiety screening questionnaire.

resultsA total of 3326 mainly female senior students participated in the study with a mean age of 21.9±1.7 years. According to the GAD-7 score, half of the sampled students did not meet criteria indicative of anxiety disorder, and one-third were considered to have mild anxiety with a significant positive correlation between the BB usage and the GAD-7 score. A total of 6.4% of the sample reported usage of BBs. Therapeutics and Internal Medicine were the most common subjects for which BBs were used. When compared to pharmacy students, medical students were more likely to be male, smokers, diagnosed with psychiatric illness, having a higher mean GAD-7 score, report BB usage, and correctly identified common and serious BB side effects.

conclusionThe inappropriate use of BB drugs without medical advice might have short- and long-term effects, and those may be more vulnerable to have psychological issues in the future. Our findings shed light on the need to identify students who are taking BBs as being at high risk of underlying anxiety disorders.

Indexed as

anxietybeta-blockerself-prescriptionstudent anxietyundiagnosed anxiety

Identifiers

PMID33762824
PMCPMC7982708
OpenAlexW3137376615

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.